Filtrer
Special Edition : Summit of the Future
Discover our special report on the Summit of the Future and the issues at stake. Analysis.
GOALKEEPERS 2024 REPORT: THE RACE TO NOURISH A WARMING WORLD
Discover our summary of the Goalkeepers 2024 annual report published ahead of the United Nations General Assembly.
Replenishment of Gavi, the Vaccine Alliance: Vaccinating half of the world’s children
Gavi, the Vaccine Alliance, intends to mobilize funding for its 2026-2030 strategy. In this special report, you'll find the latest news, facts and figures, campaigns and interviews with experts.
3 questions to Dr. Jean Kaseya, Director-General of the Africa Centres for Disease Control and Prevention
Discover the interview with Dr. Jean Kaseya, Director-General of the Africa Centres for Disease Control and Prevention.
3 questions to Pr. Yasmine Belkaid, President of the Institut Pasteur
Pr. Yasmine Belkaid, Director of Institut Pasteur, answers Focus 2030's questions and shares her experience on the challenges of vaccine research on the African continent.
3 questions to Dr. Sania Nishtar, CEO of Gavi, the Vaccine Alliance
Dr. Sania Nishtar highlights the key role played by Gavi, the Vaccine Alliance, in progress in access to vaccination, and the challenges remaining to achieve full and equitable vaccination coverage.
3 questions to Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization
Dr. Tedros Adhanom Ghebreyesus shares the contribution of the World Health Organization (WHO) to Gavi, the Vaccine Alliance, in ensuring access to immunization worldwide.
3 questions to Rafael Vilasanjuan, Director of Policy and Global Development at ISGlobal
Rafael Vilasanjuan shares his expertise on the added value of Gavi and multilateral health organizations, and on Spain's role in promoting global health.
3 questions to Jessica Posner Odede, CEO of Girl Effect
Jessica Posner Odede, CEO of Girl Effect, answers Focus 2030's questions and shares her organisation's experience in promoting vaccination against human papillomavirus.